Facial Melasma clinical trials

Explore recruiting facial melasma clinical trials.

Recruiting facial melasma studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Facial Melasma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Single-centre, randomised, double-blind, split-face comparative design clinical trial to evaluate the efficacy and safety of the topical formulation with 4% hydroquinone and 0,025% tretinoin versus the formulation with 4% hydroquinone in patients with facial melasma

Spain

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Facial Melasma trials by city

Facial Melasma in Toronto Facial Melasma in Vancouver Facial Melasma in Montreal Facial Melasma in Calgary Facial Melasma in Edmonton Facial Melasma in Ottawa Facial Melasma in Winnipeg Facial Melasma in Quebec City Facial Melasma in Hamilton Facial Melasma in Kitchener Facial Melasma in London Facial Melasma in Halifax Facial Melasma in New York Facial Melasma in Los Angeles Facial Melasma in Chicago Facial Melasma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease